21. SAT0237 The Clinical Efficacy and Safety of Abatacept for Rheumatoid Arthritis from Japanese Multi-Center Registry: 2-Year Outcomes. (10th June 2014) Authors: Hanabayashi, M.; Kojima, T.; Takahashi, N.; Kida, D.; Funahashi, K.; Hirabara, S.; Asai, S.; Yoshioka, Y.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. SAT0262 Comparison of Serum Matrix Metalloproteinase-3 Levels in Rheumatoid Arthritis after Treatment with Biologic Agents for 24 Weeks. (10th June 2014) Authors: Hattori, Y.; Kaneko, A.; Kida, D.; Takahashi, N.; Ishikawa, H.; Kanda, H.; Sato, T.; Kojima, T.; Ishiguro, N. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. THU0115 Importance of Both Disease Activity at 12 Weeks and Clinical Response up to 12 Weeks to Predict Achievement of Low Disease Activity at 52 Weeks During Abatacept Treatment in Biologics-Switching Patients with Rheumatoid Arthritis: A Multicenter Observational Cohort Study in Japan. (9th June 2015) Authors: Kojima, T.; Takahashi, N.; Kaneko, A.; Kida, D.; Hirano, Y.; Fujibayashi, T.; Yabe, Y.; Takagi, H.; Oguchi, T.; Miyake, H.; Kato, T.; Watanabe, T.; Hayashi, M.; Shioura, T.; Kanayama, Y.; Funahashi, K.; Asai, S.; Yoshioka, Y.; Terabe, K.; Takemoto, T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗